Preventive Medicine Doctors in Erie, PA Accepting Medicare

5 Preventive Medicine doctors found. Showing 1 - 5

Dr. Edward J. Mcvay, M.D. Preventive Medicine - Occupational Medicine Medicare: Medicare Enrolled Practice Location: 1910 Sassafras St, Suite 200, Erie, PA 16502 Phone: 814-452-7879    Fax: 814-452-7161

Dr. Carla Picardo, MD, MPH Preventive Medicine - Public Health & General Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 3939 W Ridge Rd Ste A200, Erie, PA 16506 Phone: 814-835-8164    Fax: 814-838-3258

Kayleigh Wagner, LAT, ATC Preventive Medicine - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 501 W 12th St, Erie, PA 16501 Phone: 814-455-3719

Janele Allison Wolbert, Preventive Medicine - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 434 Montpelier Ave, Erie, PA 16505 Phone: 814-602-2100

Stephen T. Dobosiewicz, M.D. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 1910 Sassafras St Ste 200, Erie, PA 16502 Phone: 814-452-7879    Fax: 814-455-2628

News Archive

New model predicts the impact of outbreaks such as COVID-19 on global supply chains

A transportation review written by a professor from the Berlin School of Economics and Law presents a way of analyzing the predicted impacts epidemic outbreaks have on global supply chains and describes the results of a simulation-based analysis of COVID-19 (SARS-CoV-2) as an example.

Intellect Neurosciences receives patent for Alzheimer's disease vaccine

Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.

The other COVID risks: How race, income, zip code influence who lives or dies

It started with a headache in late March. Then came the body aches.

Scientists uncover how primary protein responsible for multidrug resistance reacts to therapeutic drugs

Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.

Read more Medical News

› Verified 8 days ago